Altimmune to Announce Third Quarter 2021 Financial Results on November 10, 2021

Rhea-AI Summary

Altimmune, Inc. (Nasdaq: ALT) has announced that it will report its third quarter 2021 financial results on November 10, 2021. The management team will host a conference call at 8:30 am E.T. to discuss these results and provide a business update. Investors can participate via domestic and international dial-in numbers or join a webcast available through their official site.

Altimmune focuses on developing treatments for obesity and liver diseases, with ongoing projects like ALT-801 for NASH and HepTcell™ for chronic hepatitis B.

GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter 2021 financial results on Wednesday, November 10, 2021.

Altimmune management will host a conference call for investors beginning at 8:30 am E.T. to discuss the third quarter 2021 financial results and provide a business update.

Conference Call Information:

Date:	Wednesday, November 10
Time:	8:30 am Eastern Time
Domestic Dial-in:	(844) 615-6509
International Dial-in:	(918) 922-3148
Conference ID:	5783655
Webcast:	https://edge.media-server.com/mmc/p/zgrrmubx

About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Investor and Media Contact:
Will Brown
Chief Financial Officer
Phone: 240-654-1450
wbrown@altimmune.com

 

FAQ

When will Altimmune report its third quarter 2021 financial results?

Altimmune will report its third quarter 2021 financial results on November 10, 2021.

What time will the Altimmune Q3 2021 conference call start?

The Altimmune Q3 2021 conference call will start at 8:30 am Eastern Time.

How can I join the Altimmune Q3 2021 conference call?

You can join the conference call by dialing (844) 615-6509 for domestic or (918) 922-3148 for international participants, using conference ID 5783655, or by accessing the webcast.

What is Altimmune's focus in drug development?

Altimmune focuses on developing treatments for obesity and liver diseases, including candidates like ALT-801 for NASH and HepTcell™ for chronic hepatitis B.